
<!DOCTYPE html><HTML><HEAD>
<META HTTP-EQUIV="X-UA-Compatible" CONTENT="IE=EDGE" />
<LINK rel="stylesheet" href="CRStyleSheet.css"></LINK>
</HEAD>
<body id="theBody">
<div id="oContextHTML" style="display: none;"></div>
<div id="oContent">
<table class="Header2"><tbody><tr><td>URETER_BIOPSY</td></tr></tbody></table>
<table class="KeyValue"><tbody>
<tr>
<td width="10%" align="left" class="T1Head">Description: </td>
<td class="T1Value" colspan="5">
<table class="SubList"><tbody>
<tr>
<td class="T1Value" style="white-space: normal;">Stores data for College of American Pathologists (CAP) form 76058-URETER, RENAL PELVIS: Biopsy.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<br/>
<table class="SubHeader3"><tbody><tr><td>Primary Key</td></tr></tbody></table>
<table class="List"><tbody>
<tr>
<th>Column Name</th>
<th>Ordinal Position</th>
<th width="90%"/>
</tr>
<tr onmouseover="this.bgColor = '#FFFFD1'" onmouseout="this.bgColor='#FFFFFF'">
<td>RESULT_ID</td>
<td>1</td>
<td width="90%"/>
</tr>
</tbody></table>
<br/>
<table class="SubHeader3"><tbody><tr><td>Column Information</td></tr></tbody></table>
<table class="SubList List"><tbody>
<tr>
<th style="min-width: 0px;"/>
<th>Name</th>
<th>Type</th>
<th>Discontinued?</th>
<th width="90%"/>
</tr>
<tr>
<td class="T1Head" style="padding: 5px;">1</td>
<td class="T1Head" style="padding-right: 12px;">RESULT_ID</td>
<td class="T1Head" style="padding-right: 12px;">VARCHAR</td>
<td>No</td>
<td width="90%"/>
</tr>
<tr>
<td style="min-width: 0px;"/>
<td colspan="10"><table class="SubList List"><tbody>
<tr><td></td></tr>
<tr>
<td style="white-space: normal;"> The unique identifier for the result record.</td>
</tr>
</tbody></table></td>
</tr>
<tr style="border-bottom-width: 1px;"><td colspan="10"/></tr>
<tr style="background-color: rgb(238, 238, 238);">
<td class="T1Head" style="padding: 5px;">2</td>
<td class="T1Head" style="padding-right: 12px;">CAP_COMMENTS</td>
<td class="T1Head" style="padding-right: 12px;">VARCHAR</td>
<td>No</td>
<td width="90%"/>
</tr>
<tr style="background-color: rgb(238, 238, 238);">
<td style="min-width: 0px;"/>
<td colspan="10"><table class="SubList List"><tbody>
<tr><td></td></tr>
<tr>
<td style="white-space: normal;"> CAP synoptic form item: General comments.</td>
</tr>
</tbody></table></td>
</tr>
<tr style="border-bottom-width: 1px;"><td colspan="10"/></tr>
<tr>
<td class="T1Head" style="padding: 5px;">3</td>
<td class="T1Head" style="padding-right: 12px;">HISTO_TYPE_SPECIFY</td>
<td class="T1Head" style="padding-right: 12px;">VARCHAR</td>
<td>No</td>
<td width="90%"/>
</tr>
<tr>
<td style="min-width: 0px;"/>
<td colspan="10"><table class="SubList List"><tbody>
<tr><td></td></tr>
<tr>
<td style="white-space: normal;"> CAP synoptic form item: Specify histologic type.</td>
</tr>
</tbody></table></td>
</tr>
<tr style="border-bottom-width: 1px;"><td colspan="10"/></tr>
<tr style="background-color: rgb(238, 238, 238);">
<td class="T1Head" style="padding: 5px;">4</td>
<td class="T1Head" style="padding-right: 12px;">SPECIMEN_OTHER_SPFY</td>
<td class="T1Head" style="padding-right: 12px;">VARCHAR</td>
<td>No</td>
<td width="90%"/>
</tr>
<tr style="background-color: rgb(238, 238, 238);">
<td style="min-width: 0px;"/>
<td colspan="10"><table class="SubList List"><tbody>
<tr><td></td></tr>
<tr>
<td style="white-space: normal;"> CAP synoptic form item: Specify other specimen.</td>
</tr>
</tbody></table></td>
</tr>
<tr style="border-bottom-width: 1px;"><td colspan="10"/></tr>
<tr>
<td class="T1Head" style="padding: 5px;">5</td>
<td class="T1Head" style="padding-right: 12px;">PRIMARY_TUMOR_C_NAME</td>
<td class="T1Head" style="padding-right: 12px;">VARCHAR</td>
<td>No</td>
<td width="90%"/>
</tr>
<tr>
<td style="min-width: 0px;"/>
<td colspan="10"><table class="SubList List"><tbody>
<tr><td></td></tr>
<tr>
<td style="white-space: normal;"> CAP synoptic form item: Primary Tumor (pT).</td>
</tr>
<tr>
<td>May contain organization-specific values: Yes</td>
</tr>
<tr>
<td> Category Entries: </td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pTX: Cannot be determined</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pTX: Cannot be assessed, or tumor proven by presence of malignant cells in sputum or</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pTX: Cannot be assessed</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT0: No evidence of primary tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pTis: Carcinoma in situ</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pTis (DCIS): Ductal carcinoma in situ</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pTis (LCIS): Lobular carcinoma in situ</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pTis (Paget): Paget disease of the nipple NOT associated with invasive carcinoma and</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pTis: Carcinoma in situ, intraepithelial (no invasion)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pTis: Carcinoma in situ, invasion of lamina propria</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pTis: High-grade dysplasia / carcinoma in situ</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pTis: Tubal intraepithelial carcinoma (limited to tubal mucosa)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pTis: Melanoma in situ (i.e., not an invasive tumor: anatomic level I)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Encapsulated</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Extracapsular extension without adjacent organ involvement</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Extension into adjacent organs</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Extension into spinal canal</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pTa: Papillary noninvasive carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pTa: Noninvasive papillary carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pTis: Intratubular germ cell neoplasia only (carcinoma in situ)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pTis: Flat carcinoma in situ</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pTis: Carcinoma in situ: flat tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Iris</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Ciliary Body and Choroid</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1: Tumor 5 cm or less in greatest dimension, no extra-adrenal invasion</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1: Tumor limited to ampulla of Vater or sphincter of Oddi</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1: Tumor 2 cm or less in greatest dimension</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1: Tumor invades submucosa</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1: Tumor confined to the bile duct histologically</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1: Solitary tumor without vascular invasion</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1: Tmr confined to bile duct, w/ extension up to muscle layer or fibrous tissue</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1: Tumor 8 cm or less in greatest dimension</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1mi: Tumor &lt;= 1 mm in greatest dimension (microinvasion)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1a: Tumor &gt; 1 mm but &lt;= 5 mm in greatest dimension</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1b: Tumor &gt; 5 mm but &lt;= 10 mm in greatest dimension</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1c: Tumor &gt; 10 mm but &lt;= 20 mm in greatest dimension</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1a (IA): Tumor limited to endometrium or invades less than one-half of myometrium</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1b (IB): Tumor invades greater than or equal to one-half of the myometrium</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1: Tumor invades lamina propria, muscularis mucosae, or submucosa</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1a: Tumor invades lamina propria or muscularis mucosae</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1a: Tumor invades lamina propria</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1 (I): Tumor limited to fallopian tube(s)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1a (IA): Tumor limited to 1 tube without penetrating serosal surface; no ascites</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1b (IB): Tumor limited to both tubes w/o penetrating serosal surface; no ascites</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1c (IC): Tmr limited to 1 or both tube(s) w/ extension into or through tubal serosa</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1b: Tumor invades submucosa</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1b: Tumor invades muscle layer</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1: Tumor 7 cm or less in greatest dimension, limited to the kidney</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1a: Tumor 4 cm or less in greatest dimension, limited to the kidney</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1b: Tumor &gt; 4cm but not more than 7cm in greatest dimension, limited to  kidney</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1a: Tumor 2 cm or less in greatest dimension, surrounded by lung or visceral pleura</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1b: Tumor greater than 2 cm, but 3 cm or less in greatest dimension, surrounded by </td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1: Tumor &lt;=2cm in greatest dimension (without extraparenchymal extension) (Note I)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1a: Tumor limited to ipsilateral parietal pleura with or without mediastinal or</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1b: Tumor involves ipsilateral parietal pleura with or without mediastinal or</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1a: Melanoma 1.0 mm or less in thickness, no ulceration, &lt;1 mitoses / mm*mm</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1b: Melanoma 1.0 mm or less in thickness with ulceration and/or 1+ mitoses/mm*mm</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1a (IA): Tumor limited to one ovary; capsule intact, no tumor on ovarian surface. N</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1b (IB): Tumor limited to both ovaries; capsule intact, no tumor on ovarian surface</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1c (IC): Tumor limited to one or both ovaries with any of the following: capsule </td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1: Tumor limited to the pancreas, 2 cm or less in greatest dimension</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pN1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimen</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1: Tumor confined to nasopharynx, or tumor extends to oropharynx and / or nasal</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1: Tmr limited to one subsite of hypopharynx and/or 2 cm or less in greatest dimen</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1: Tumor invades subepithelial connective tissue (lamina propria)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1: Tumor confined to the eye with no optic nerve or choroidal invasion</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1a: Tumor 5 cm or less in greatest dimension, superficial tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1b: Tumor 5 cm or less in greatest dimension, deep tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1: Tumor 2 cm or less in greatest dimension with less than two high risk features</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1: Tumor limited to the testis and epididymis without vascular / lymphatic invasion</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1: Tumor size 2 cm or less, limited to thyroid</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1a: Tumor 1 cm or less in greatest dimension limited to the thyroid</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1b: Tmr more than 1 cm but not more than 2cm in greatest dimen., limited to thyroid</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1 (I): Tumor confined to uterus</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1a (IA): Invasive carcinoma diagnosed by microscopy only. All macroscopically</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1a1 (IA1): Stromal invasion 3.0mm or less in depth, horizontal spread 7.0mm or less</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1a2 (IA2): Stromal invasion more than 3.0 mm but not more than 5.0 mm in depth</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1b (IB): Clinically visible lesion confined to cervix/microscopic lesion &gt; T1a2/IA2</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1b1 (IB1): Clinically visible lesion 4.0 cm or less in greatest dimension</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1b2 (IB2): Clinically visible lesion more than 4.0 cm in greatest dimension</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1 (I): Tumor confined to vaginal wall</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1a (FIGO IA): Lesions 2 cm or less in size, confined to the vulva or perineum</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT1b (FIGO IB): Lesions more than 2 cm in size or any size with stromal invasion more</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2: Tumor greater than 5 cm, no extra-adrenal invasion</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2: Tumor invades duodenal wall</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2: Tumor more than 2 cm but not more than 5 cm in greatest dimension</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2: Tumor invades muscularis propria</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2: Tumor invades beyond the wall of the bile duct</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2a: Solitary tumor with vascular invasion</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2b: Multiple tumors, with or without vascular invasion</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2a: Tumor invades beyond the wall of the bile duct to surrounding adipose tissue</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2b: Tumor invades adjacent hepatic parenchyma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2: Tumor more than 8 cm in greatest dimension</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2: Tumor &gt; 20 mm but &lt;= 50 mm in greatest dimension</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2 (II): Tumor invades stromal connective tissue of the cervix, but does not extend </td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2 (II): Tumor involves 1 or both tube(s) with pelvic extension</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2a (IIA): Extension and / or metastasis to the uterus and / or ovaries</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2b (IIB): Extension to other pelvic structures</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2c (IIC): Pelvic extension (T2a,T2b/IIA or IIB) w/ malignant cells in ascites</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2: Tmr invades perimuscular connective tissue; no extension beyond serosa/in liver</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2: Solitary tumor with vascular invasion or multiple tumors none more than 5 cm</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2: Tumor more than 7 cm in greatest dimension, limited to the kidney</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2a: Tumor more than 7 cm but &gt;= 10 cm in greatest dimension, limited to kidney</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2b: Tumor more than 10 cm, limited to the kidney</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2a: Tumor greater than 3 cm, but 5 cm or less in greatest dimension surrounded by l</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2b: Tumor greater than 5 cm, but 7 cm or less in greatest dimension</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2: Tumor &gt;2cm but &lt;=4cm in greatest dimension (without extraparenchymal extension)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2: Tumor involves each of the ipsilateral pleural surfaces (parietal, mediastinal, </td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2a: Melanoma 1.01 to 2.0 mm in thickness, no ulceration</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2b: Melanoma 1.01 to 2.0 mm in thickness, with ulceration</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2a (IIA): Extension and / or implants on uterus and / or tube(s). No malignant cell</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2b (IIB): Extension to other pelvic tissues. No malignant cells in ascites or</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2c (IIC): Pelvic extension and/or implants (T2a or T2b / IIa or IIb) with malignant</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2: Tumor limited to the pancreas, more than 2 cm in greatest dimension</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pN2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than </td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2: Tumor with parapharyngeal extension</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2: Tumor invades more than one subsite of hypopharynx or an adjacent site, or</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2: Organ confined</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2a: Unilateral, involving one-half of 1 side or less</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2b: Unilateral, involving more than one-half of 1 side but not both sides</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2c: Bilateral disease</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2a: Tmr invades optic nerve head no extend past lamina or focal choroidal invasion</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2b: Tmr invades optic nerve head no extend past lamina and focal choroidal invasion</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2a: Tumor more than 5 cm in greatest dimension, superficial tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2b: Tumor more than 5 cm in greatest dimension, deep tumor</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2: Tumor greater than 2 cm in greatest dimension with or without one additional</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2: Tumor limited to the testis and epididymis with vascular / lymphatic invasion</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2: Tumor more than 2 cm, but not more than 4 cm, limited to thyroid </td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2 (II): Tumor extends outside of the uterus but is limited to genital structures</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2a: Tumor invades superficial muscularis propria (inner half)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2b: Tumor invades deep muscularis propria (outer half)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2a (IIA): Tumor without parametrial invasion</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2a1 (IIA1): Clinically visible lesion less than or equal to 4.0cm in greatest dimen</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2a2 (IIA2): Clinically visible lesion greater than 4.0 cm in greatest dimension</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2b (IIB): Tumor with parametrial invasion</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2 (II): Tumor invades paravaginal tissues but not the pelvic wall</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT2 (FIGO II): Tumor of any size with extension to adjacent perineal structures </td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3: Tumor of any size with local invasion, but not invading adjacent organs</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3: Tumor invades pancreas</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3: Tumor more than 5 cm in greatest dimension</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3: Tumor invades through the muscularis propria into the subserosa or mesoappendix</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3: Tmr invades gallbladder,pancreas,duodenum,other adj. organs w/o involvement of</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3: Tmr perforates visc. peritoneum/invol local extrahepatic struct. by direct invas</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3: Tumor invades unilateral branches of the portal vein or hepatic artery</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3: Discontinuous tumors in primary bone site (not including skip metastases)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3: Tumor &gt; 50 mm in greatest dimension</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3: Tumor invades through the muscularis propria into pericolorectal tissues</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3a (IIIA): Tumor involves serosa and / or adnexa (direct extension or metastasis)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3b (IIIB): Vaginal involvement (direct extension/metastasis) or parametrial involve</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3: Tumor invades adventitia</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3/N1 (III): Tmr involves 1 or both tube(s) with peritoneal implants outside pelvis</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3a (IIIA): Microscopic peritoneal metastasis beyond pelvis</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3b (IIIB): Macroscopic peritoneal metastasis beyond pelvis &lt;=2cm in greatest dimen</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3c / NI (IIIC): Peritoneal metastasis beyond pelvis &gt;2cm in greatest dimen</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3: Tumor perforates serosa (visceral peritoneum) and/or directly invades the liver</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3a: Multiple tumors more than 5 cm</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3b: Single/multiple tmrs any size involving major branch of portal/hepatic veins</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3: Tmr extends into major veins/perinephric tissues, not into ipsilateral adrenal</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3a: Tumor grossly extends into the renal vein or its segmental (muscle containing) </td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3b: Tumor grossly extends into the vena cava below the diaphragm</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3c: Tmr grossly extends into vena cava above diaphragm or invades wall of vena cava</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3: Mucosal disease</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3: Tumor more than 4 cm in greatest dimension</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3: Tumor greater than 7 cm in greatest dimension; or Tumor of any size that</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3: Tumor more than 4 cm and / or tumor (having extraparenchymal extension) (Note I)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3: Locally advanced but potentially resectable tumor that involves all of the</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3a: Melanoma 2.01 to 4.0 mm in thickness, no ulceration</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3b: Melanoma 2.01 to 4.0 mm in thickness, with ulceration</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3a (IIIA): Microscopic peritoneal metastasis beyond pelvis (no macroscopic tumor)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3b (IIIB): Macroscopic peritoneal metastasis beyond pelvis &lt;=2 cm in greatest dimen</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3c and / or N1 (IIIC): Peritoneal metastasis beyond pelvis &gt;2 cm in greatest dimen</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3: Tumor extends beyond the pancreas but without involvement of the celiac axis or </td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3: Tmr &gt;4 cm in greatest dimension/extension to lingual surface of epiglottis</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3: Tumor invades bony structures of skull base and / or paranasal sinuses</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3: Tumor measures more than 4 cm in greatest dimension or with fixation of hemilary</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3a: Extraprostatic extension or microscopic invasion of bladder neck</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3b: Seminal vesicle invasion</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3: Tumor invades beyond muscularis into peripelvic fat or the renal parenchyma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3a: Tumor invades optic nerve past lamina cribrosa OR focal choroidal invasion</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3b: Tumor invades optic nerve past lamina cribrosa AND focal choroidal invasion</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3: Tumor invades through the muscularis propria into the subserosa or into the</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3: Tumor with invasion of maxilla, mandible, orbit, or temporal bone</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3: Tumor invades subserosal connective tissue, without involvement of</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3: Tumor invades spermatic cord with or without vascular / lymphatic invasion</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3: Tumor &gt;4 cm limited to thyroid or any tumor with minimal extrathyroid extension</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3: Tumor invades beyond muscularis propria into periureteric fat</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3a: Microscopically</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3b: Macroscopically (extravesicular mass)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3a (IIIA): Tumor involves lower third of vagina, but not pelvic wall</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3b (IIIB): Tmr extend to pelvic wall and/or causes hydronephrosis/non-funct. kidney</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3 (III): Tumor extends to pelvic wall</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT3 (FIGO IVA): Tumor of any size with extension to any of the following</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4: Tumor of any size with invasion of adjacent organs</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4: Tumor invades peripancreatic soft tissues or other adjacent organs or structures</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4: Tmr of any size w/ invasion of adjacent organ(s) e.g. vagina, urethra, bladder</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4: Tumor penetrates visceral peritoneum, including mucinous peritoneal tumor within</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4: Tumor involves the celiac axis or the superior mesenteric artery</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4: Tumor with periductal invasion</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4: Tumor invades main portal vein or its branches bilaterally; or the common hepati</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4 (IVA): Tumor invades bladder mucosa and/or bowel mucosa </td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4: Tumor invades adjacent structures </td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4: Tumor invades main portal vein or hepatic artery or invades 2+ extrahepatic</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4: Tmr w/ direct invasion of adj. organs other than gallbladder </td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4: Tmr invades beyond Gerota’s fascia</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4: Tumor of any size that invades any of the following: mediastinum, heart, great</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4: Locally advanced technically unresectable tumor involving all of the ipsilateral</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4: Tumor with intracranial extension and / or involvement of cranial nerves,</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4: Invasion of rectum, levator muscles, and / or pelvic wall (Note J)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4: Tumor invades adjacent organs, or through the kidney into the perinephric fat</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4a: Tmr invades optic nerve to resection line, no extra-ocular extension identified</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4b: Tumor invades optic nerve to resection line, extra-ocular extension identified</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4: Tumor with direct or perineural invasion of skull base or axial skeleton</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4: Tmr involves visc. peritoneum (serosal surf.) or directly invades adj. structure</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4: Tumor invades scrotum with or without vascular / lymphatic invasion</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4: Tumor invades adjacent organs</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4 (IVA): Tmr invades the mucosa of bladder/rectum and/or extends beyond true pelvis</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4 (IVA): Tmr invades mucosa of bladder or rectum and/or extends beyond true pelvis</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4a: Tumor penetrates visceral peritoneum, including mucinous peritoneal tumor withi</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4a: Tumor penetrates the visceral peritoneum</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4a: Extension to chest wall, not including only pectoralis muscle adherence / invas</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4b: Ulceration/ipsilateral satellite nodules/edema of skin which dont meet criteria</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4c: Both T4a and T4b</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4d: Inflammatory carcinoma</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4b: Tumor directly invades other organs or structures</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4b: Tumor directly invades or is adherent to other organs or structures</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4a: Resectable tumor invading pleura, pericardium, or diaphragm</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4b: Unresectable tmr invading other adj. structures, such as aorta, vertebral body</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Any T / Any N and M1 (IV): Distant metastasis including presence of malignant cells</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Primary Tumor (pT): Supraglottis</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Primary Tumor (pT): Glottis</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Primary Tumor (pT): Subglottis</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4a: Moderately advanced disease. Tumor involving deep soft tissue, cartilage, bone,</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4b: Very advanced disease. Tumor involving brain, dura, skull base,</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4a: Moderately advanced local disease.</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4b: Very advanced local disease. </td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4a: Moderately advanced local disease. Tumor invades skin, mandible, ear canal,</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4b: Very advanced local disease. Tumor invades skull base and / or pterygoid plates</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4a: Melanoma greater than 4.0 mm in thickness, no ulceration</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4b: Melanoma greater than 4.0 mm in thickness, with ulceration</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Primary Tumor (pT): Maxillary Sinus</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Primary Tumor (pT): Nasal Cavity and Ethmoid Sinus</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4a: Moderately advanced local disease. Tumor invades larynx, deep / extrinsic</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4b: Very advanced local disease. Tumor invades lateral pterygoid muscle, pterygoid </td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4a: Moderately advanced local disease. Tumor invades thyroid / cricoid cartilage,</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4b: Very advanced local disease. Tumor invades prevertebral fascia, encases</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4a: Tumor involves visceral peritoneum (serosal surface)</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4b: Tumor directly invades adjacent structures</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4a: Moderately advanced disease. Tumor of any size extending beyond the thyroid</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4b: Very advanced disease. Tumor invades prevertebral fascia or encases carotid</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4a: Intrathyroidal anaplastic carcinoma-surgically resectable</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4b: Extrathyroidal anaplastic carcinoma-surgically unresectable</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4a: Tumor invades prostatic stroma or uterus or vagina</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">pT4b: Tumor invades pelvic wall or abdominal wall</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Not identified</td>
</tr>
</tbody></table></td>
</tr>
<tr style="border-bottom-width: 1px;"><td colspan="10"/></tr>
<tr style="background-color: rgb(238, 238, 238);">
<td class="T1Head" style="padding: 5px;">6</td>
<td class="T1Head" style="padding-right: 12px;">ADDL_PATH_FIND_SPFY</td>
<td class="T1Head" style="padding-right: 12px;">VARCHAR</td>
<td>No</td>
<td width="90%"/>
</tr>
<tr style="background-color: rgb(238, 238, 238);">
<td style="min-width: 0px;"/>
<td colspan="10"><table class="SubList List"><tbody>
<tr><td></td></tr>
<tr>
<td style="white-space: normal;"> CAP synoptic form item: Specify additional pathologic findings.</td>
</tr>
</tbody></table></td>
</tr>
<tr style="border-bottom-width: 1px;"><td colspan="10"/></tr>
<tr>
<td class="T1Head" style="padding: 5px;">7</td>
<td class="T1Head" style="padding-right: 12px;">OTHER_TM_CONFIG_S</td>
<td class="T1Head" style="padding-right: 12px;">VARCHAR</td>
<td>No</td>
<td width="90%"/>
</tr>
<tr>
<td style="min-width: 0px;"/>
<td colspan="10"><table class="SubList List"><tbody>
<tr><td></td></tr>
<tr>
<td style="white-space: normal;"> CAP synoptic form item: Specify other tumor configuration.</td>
</tr>
</tbody></table></td>
</tr>
<tr style="border-bottom-width: 1px;"><td colspan="10"/></tr>
<tr style="background-color: rgb(238, 238, 238);">
<td class="T1Head" style="padding: 5px;">8</td>
<td class="T1Head" style="padding-right: 12px;">ADQCY_DETER_T_CAT_C_NAME</td>
<td class="T1Head" style="padding-right: 12px;">VARCHAR</td>
<td>No</td>
<td width="90%"/>
</tr>
<tr style="background-color: rgb(238, 238, 238);">
<td style="min-width: 0px;"/>
<td colspan="10"><table class="SubList List"><tbody>
<tr><td></td></tr>
<tr>
<td style="white-space: normal;"> CAP synoptic form item: Adequacy of Material for Determining T Category.</td>
</tr>
<tr>
<td>May contain organization-specific values: Yes</td>
</tr>
<tr>
<td> Category Entries: </td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Muscularis propria not identified</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Muscularis propria present</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Indeterminate</td>
</tr>
</tbody></table></td>
</tr>
<tr style="border-bottom-width: 1px;"><td colspan="10"/></tr>
<tr>
<td class="T1Head" style="padding: 5px;">9</td>
<td class="T1Head" style="padding-right: 12px;">HG_URTL_CCNM_C_NAME</td>
<td class="T1Head" style="padding-right: 12px;">VARCHAR</td>
<td>No</td>
<td width="90%"/>
</tr>
<tr>
<td style="min-width: 0px;"/>
<td colspan="10"><table class="SubList List"><tbody>
<tr><td></td></tr>
<tr>
<td style="white-space: normal;"> CAP synoptic form item: Histologic Grade Urothelial Carcinoma.</td>
</tr>
<tr>
<td>May contain organization-specific values: Yes</td>
</tr>
<tr>
<td> Category Entries: </td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Low-grade</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">High-grade</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Not applicable</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Cannot be determined</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Other</td>
</tr>
</tbody></table></td>
</tr>
<tr style="border-bottom-width: 1px;"><td colspan="10"/></tr>
<tr style="background-color: rgb(238, 238, 238);">
<td class="T1Head" style="padding: 5px;">10</td>
<td class="T1Head" style="padding-right: 12px;">HG_URTL_CCNM_S</td>
<td class="T1Head" style="padding-right: 12px;">VARCHAR</td>
<td>No</td>
<td width="90%"/>
</tr>
<tr style="background-color: rgb(238, 238, 238);">
<td style="min-width: 0px;"/>
<td colspan="10"><table class="SubList List"><tbody>
<tr><td></td></tr>
<tr>
<td style="white-space: normal;"> CAP synoptic form item: Specify the details of Histologic Grade Urothelial carcinoma.</td>
</tr>
</tbody></table></td>
</tr>
<tr style="border-bottom-width: 1px;"><td colspan="10"/></tr>
<tr>
<td class="T1Head" style="padding: 5px;">11</td>
<td class="T1Head" style="padding-right: 12px;">HG_ADEN_SQUA_CC_C_NAME</td>
<td class="T1Head" style="padding-right: 12px;">VARCHAR</td>
<td>No</td>
<td width="90%"/>
</tr>
<tr>
<td style="min-width: 0px;"/>
<td colspan="10"><table class="SubList List"><tbody>
<tr><td></td></tr>
<tr>
<td style="white-space: normal;"> CAP synoptic form item: Histologic Grade Adenocarcinoma and Squamous Cell Carcinoma.</td>
</tr>
<tr>
<td>May contain organization-specific values: Yes</td>
</tr>
<tr>
<td> Category Entries: </td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Not applicable</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Cannot be determined</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">GX: Cannot be assessed</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">G1: Well differentiated</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">G2: Moderately differentiated</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">G3: Poorly differentiated</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Other</td>
</tr>
</tbody></table></td>
</tr>
<tr style="border-bottom-width: 1px;"><td colspan="10"/></tr>
<tr style="background-color: rgb(238, 238, 238);">
<td class="T1Head" style="padding: 5px;">12</td>
<td class="T1Head" style="padding-right: 12px;">ADEN_SQUA_CCS</td>
<td class="T1Head" style="padding-right: 12px;">VARCHAR</td>
<td>No</td>
<td width="90%"/>
</tr>
<tr style="background-color: rgb(238, 238, 238);">
<td style="min-width: 0px;"/>
<td colspan="10"><table class="SubList List"><tbody>
<tr><td></td></tr>
<tr>
<td style="white-space: normal;"> CAP synoptic form item: Specify Histologic Grade Adenocarcinoma and Squamous Cell Carcinoma.</td>
</tr>
</tbody></table></td>
</tr>
<tr style="border-bottom-width: 1px;"><td colspan="10"/></tr>
<tr>
<td class="T1Head" style="padding: 5px;">13</td>
<td class="T1Head" style="padding-right: 12px;">UROT_CCM_W_VAR_HIST</td>
<td class="T1Head" style="padding-right: 12px;">VARCHAR</td>
<td>No</td>
<td width="90%"/>
</tr>
<tr>
<td style="min-width: 0px;"/>
<td colspan="10"><table class="SubList List"><tbody>
<tr><td></td></tr>
<tr>
<td style="white-space: normal;"> CAP synoptic form item: Specify the details of Urothelial carcinoma with variant histology.</td>
</tr>
</tbody></table></td>
</tr>
<tr style="border-bottom-width: 1px;"><td colspan="10"/></tr>
<tr style="background-color: rgb(238, 238, 238);">
<td class="T1Head" style="padding: 5px;">14</td>
<td class="T1Head" style="padding-right: 12px;">SQM_C_CCNM_VAR_HIST</td>
<td class="T1Head" style="padding-right: 12px;">VARCHAR</td>
<td>No</td>
<td width="90%"/>
</tr>
<tr style="background-color: rgb(238, 238, 238);">
<td style="min-width: 0px;"/>
<td colspan="10"><table class="SubList List"><tbody>
<tr><td></td></tr>
<tr>
<td style="white-space: normal;"> CAP synoptic form item: Specify the details of Squamous cell carcinoma, variant histology.</td>
</tr>
</tbody></table></td>
</tr>
<tr style="border-bottom-width: 1px;"><td colspan="10"/></tr>
<tr>
<td class="T1Head" style="padding: 5px;">15</td>
<td class="T1Head" style="padding-right: 12px;">ADNCCNM_VAR_HIST</td>
<td class="T1Head" style="padding-right: 12px;">VARCHAR</td>
<td>No</td>
<td width="90%"/>
</tr>
<tr>
<td style="min-width: 0px;"/>
<td colspan="10"><table class="SubList List"><tbody>
<tr><td></td></tr>
<tr>
<td style="white-space: normal;"> CAP synoptic form item: Specify the details of Adenocarcinoma, variant histology.</td>
</tr>
</tbody></table></td>
</tr>
<tr style="border-bottom-width: 1px;"><td colspan="10"/></tr>
<tr style="background-color: rgb(238, 238, 238);">
<td class="T1Head" style="padding: 5px;">16</td>
<td class="T1Head" style="padding-right: 12px;">UNDIFF_CCNM</td>
<td class="T1Head" style="padding-right: 12px;">VARCHAR</td>
<td>No</td>
<td width="90%"/>
</tr>
<tr style="background-color: rgb(238, 238, 238);">
<td style="min-width: 0px;"/>
<td colspan="10"><table class="SubList List"><tbody>
<tr><td></td></tr>
<tr>
<td style="white-space: normal;"> CAP synoptic form item: Specify the details of undifferentiated carcinoma.</td>
</tr>
</tbody></table></td>
</tr>
<tr style="border-bottom-width: 1px;"><td colspan="10"/></tr>
<tr>
<td class="T1Head" style="padding: 5px;">17</td>
<td class="T1Head" style="padding-right: 12px;">HIST_TP_MIX_CT</td>
<td class="T1Head" style="padding-right: 12px;">VARCHAR</td>
<td>No</td>
<td width="90%"/>
</tr>
<tr>
<td style="min-width: 0px;"/>
<td colspan="10"><table class="SubList List"><tbody>
<tr><td></td></tr>
<tr>
<td style="white-space: normal;"> CAP synoptic form item: Specify the details of mixed cell type.</td>
</tr>
</tbody></table></td>
</tr>
<tr style="border-bottom-width: 1px;"><td colspan="10"/></tr>
<tr style="background-color: rgb(238, 238, 238);">
<td class="T1Head" style="padding: 5px;">18</td>
<td class="T1Head" style="padding-right: 12px;">HIST_GRADE_CBD_YN</td>
<td class="T1Head" style="padding-right: 12px;">VARCHAR</td>
<td>No</td>
<td width="90%"/>
</tr>
<tr style="background-color: rgb(238, 238, 238);">
<td style="min-width: 0px;"/>
<td colspan="10"><table class="SubList List"><tbody>
<tr><td></td></tr>
<tr>
<td style="white-space: normal;"> CAP synoptic form item: Histologic Grade Cannot Be Determined.</td>
</tr>
<tr>
<td>May contain organization-specific values: No</td>
</tr>
<tr>
<td> Category Entries: </td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">No</td>
</tr>
<tr>
<td style="padding-left: 100px;word-break: break-all;white-space: pre-wrap;overflow-wrap: anywhere;">Yes</td>
</tr>
</tbody></table></td>
</tr>
<tr style="border-bottom-width: 1px;"><td colspan="10"/></tr>
</tbody></table>
<br/><br/>
<br/><br/>
</div></body></HTML>